Skip to content

Clinical trials

Phase 1/2 Pneumonia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pneumonia Phase: Phase 1/2 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20082
20121
20141
20161
20191
202010
20212
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status6
Recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARI Research Cell2
Aridis Pharmaceuticals, Inc.1
Aspire Health Science1
Cairo University1
Celularity Incorporated1
Clarassance, Inc.1
Critical Biologics Corporation1
D'Or Institute for Research and Education1
EXO Biologics S.A.1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pneumonia28
COVID-1913
Coronavirus Infections7
Respiratory Distress Syndrome5
Lung Diseases3
Bronchopulmonary Dysplasia2
Cytokine Release Syndrome2
Influenza, Human2
Pneumonia, Viral2
Severe Acute Respiratory Syndrome2

Trials

Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.